Editorial and Publishing Staff

Article

John C. Hayes Editorial DirectorShalmali Pal News EditorAnne Landry, Ronald Piana Feature EditorsTerri Gelfand Managing EditorLisa Katz Creative DirectorNancy Bitteker Group Creative DirectorCarolyn Harrington Art DirectorBarbara Boughton, Catherine Donnelly, Jordana Bieze Foster, Caroline Helwick, Susan London, June Skinner, Kathlyn Stone, Steven Wagner Contributing WritersAndrew Barkus Group Production ManagerAmy Birnbach Associate PublisherChrissy Sheehan Advertising CoordinatorCara H. Glynn Senior Editorial DirectorKathy Mischak Group PublisherBeth Scholz Senior Vice President, Oncology and RadiologyBeatrix Eriksen Vice President, Research Marketing, and CirculationAmy Erdman Director of ResearchColleen Tricarico Circulation Manager

John C. Hayes
Editorial Director
Shalmali Pal
News Editor
Anne Landry, Ronald Piana
Feature Editors
Terri Gelfand
Managing Editor
Lisa Katz
Creative Director
Nancy Bitteker
Group Creative Director
Carolyn Harrington
Art Director
Barbara Boughton, Catherine Donnelly, Jordana Bieze Foster, Caroline Helwick, Susan London, June Skinner, Kathlyn Stone, Steven Wagner
Contributing Writers
Andrew Barkus
Group Production Manager
Amy Birnbach
Associate Publisher
Chrissy Sheehan
Advertising Coordinator
Cara H. Glynn
Senior Editorial Director
Kathy Mischak
Group Publisher
Beth Scholz
Senior Vice President, Oncology and Radiology
Beatrix Eriksen
Vice President, Research Marketing, and Circulation
Amy Erdman
Director of Research
Colleen Tricarico
Circulation Manager

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content
Phase 3 data support using twice-daily high-dose thoracic radiotherapy plus concurrent chemotherapy as an alternative therapy for patients with LS-SCLC.

High-Dose Radiotherapy Boosts Survival Without Toxicity Increase in LS-SCLC

Russ Conroy
April 20th 2025
Article

Phase 3 data support using twice-daily high-dose thoracic radiotherapy plus concurrent chemotherapy as an alternative therapy for patients with LS-SCLC.

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Cristiane Decat Bergerot, PhD
April 14th 2025
Podcast

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

End-of-life demands card game and mindfulness-based cancer recovery program use may enhance the quality of life for patients with lung cancer.

Mindfulness/Activity Program May Ease Anxiety Over Death from Lung Cancer

Roman Fabbricatore
April 19th 2025
Article

End-of-life demands card game and mindfulness-based cancer recovery program use may enhance the quality of life for patients with lung cancer.

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Elevating the Quality of Cancer Care via Cross-Department Collaboration

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD
April 7th 2025
Podcast

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

96 Elacestrant Real-World Progression-Free Survival of Adult Patients With ER+/HER2–, Advanced Breast Cancer: A Retrospective Analysis Using Insurance Claims in the United States

96 Elacestrant Real-World Progression-Free Survival of Adult Patients With ER+/HER2–, Advanced Breast Cancer: A Retrospective Analysis Using Insurance Claims in the United States

Elyse Swallow;Jessica Maitland;Kirthana Sarathy;Ellen Sears;Yasir Nagarwala;Janelle DePalantino;Eric Kruep;Corey Pelletier;Sebastian Kloss;Tomer Wasserman
April 18th 2025
Article
Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.

Classification System May Identify QOL Benefit with Palliative Radiotherapy

Roman Fabbricatore
April 18th 2025
Article

Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.